nach oben

Erschienen in:

2009 | OriginalPaper | Buchkapitel

7. Galacto-Oligosaccharide Prebiotics

verfasst von : George Tzortzis, Jelena Vulevic

Erschienen in: Prebiotics and Probiotics Science and Technology

Verlag: Springer New York

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

The wide recognition of bifidobacteria as health promoting bacteria (Boesten and de Vos, 2008) has attracted a lot of interest in identifying substances that can selectively promote their growth. Many studies using conventional culture and molecular techniques for bacterial identification have shown that breast-fed infants are characterized by an intestinal microbiota that is dominated by bifidobacteria (Benno et al., 1984), which is different from that of infants fed on cow’s milk in that their microbiotas are characterized by lower counts of bifidobacteria, with greater numbers of more potentially harmful organisms such as clostridia and enterococci (Lunderquist et al., 1985). As a result of this difference in the microbiota composition, higher levels of ammonia, amines and phenols and other potentially harmful substances have also been found in infants fed cow’s milk products (Lunderquist et al., 1985).

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Fructan Prebiotics Derived from Inulin

Nächstes Kapitel Prebiotic Potential of Xylo-Oligosaccharides

Abe C, Fujita K, Kikuchi E, Hirano S, Kuboki H, Yamashita A, Hashimoto H, Mori S, OkadaM (2004) Effects of alpha-linked galactooligosaccharide on adjuvant-induced arthritis in Wistar rats and type II collagen-induced arthritis in DBA/1J mice. Int J Tissue React 26:65–73

Amaretti A, Bernardi T, Tamburini E, Zanoni S, Lomma M, Matteuzzi D, Rossi M (2007) Kinetics and metabolism of Bifidobacterium adolescentis MB 239 growing on glucose, galactose, lactose, and galactooligosaccharides. Appl Environ Microbiol 73:3637–3644CrossRef

Anthony JC, Merriman TN, Heimbach JT (2006) 90-day oral (gavage) study in rats with galactooligosaccharides syrup. Food Chem Toxicol 819–826

Bakker-Zierikzee AM, van Tol EAF, Kroes H, Alles MS, Kok FJ, Bindels JG (2006) Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr Allergy Immunol 17:134–140CrossRef

Benno Y, Sawada K, Mitsuoka T (1984) The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 28:975–986

Bode L (2006) Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr 136:2127–2130

Boehm G, Lidestri M, Casseta P, Jelinek J, Negretti F, Stahl B, Marini A (2002) Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed 86:F178–F181CrossRef

Boehm G, Stahl B, Jelinek J, Knol J, Miniello V, Moro GE (2005) Prebiotic carbohydrates in human milk and formulas. Acta Pediatr 94:18–21CrossRef

Boesten RJ, de Vos WM (2008) Interactomics in the human intestine: Lactobacilli and Bifidobacteria make a difference. J Clin Gastroenterol 42(Pt 2):S163–S167CrossRef

Boon MA, van’t Riet K, Janssen AEM (2000) Enzymatic synthesis of oligosaccharides: Product removal during a kinetically controlled reaction. Biotechnol Bioeng 70:411–420CrossRef

Bouhnik Y, Flourie B, D’Agay-Abensour L, Pochart P, Gramet G, Durand M, Rambaud JC (1997) Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr 127:444–448

Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Flourie B, Brouns F, Bornet FR (2004) The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 80:1658–1664

Chonan O, Watanuki M (1996) The effect of 6′-galactooligosaccharides on bone mineralization of rats adapted to different levels of dietary calcium. Int J Vitam Nutr Res 66:244–249

Chonan O, Matsumoto K, Watanuki M (1995) Effect of galactooligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats. Biosci Biotech Biochem 59:236–239CrossRef

Chonan O, Takahashi R, Yasui H, Watanuki M (1996) Effects of beta 1–4 linked galactooligosaccharides on use of magnesium and calcification of the kidney and heart in rats fed excess dietary phosphorous and calcium. Biosci Biotech Biochem 60: 1735–1737CrossRef

Cummings JH, Roberfroid MB, Anderson H, Barth C, Ferro-Luzzi A, Ghoos Y, Gibney M, Hermonsen K, James WPT, Korver O, Lairon D, Pascal G, Voragen AGS (1997) PASSCLAIM –Gut health and immunity. Eur J Clin Nutr 51:417–423CrossRef

Deguchi Y, Matsumoto K, Ito T, Watanuki M (1997) Effects of b1-4 galacto-oligosaccharides administration on defecation of healthy volunteers with constipation tendency. Jpn J Nutr 55:13–22

Depeint F, Tzortzis G, Vulevic J, I’Anson K, Gibson GR (2008) Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr 87:785–791

Desjardins ML, Roy D (1990) Uncoupling of growth and acids production in Bifidobacterium ssp. J Dairy Sci 73:299–307CrossRef

van Dokkum W, Wezendonk B, Srikumar TS, van den Heuvel EGHM (1999) Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 53:1–7CrossRef

Gopal KP, Sullivan PA, Smart JB (2001) Utilisation of galacto-oligosaccharides as selective substrates for growth by lactic acid bacteria including Bifidobacterium lactis DR10 and Lactobacillus rhamnosus DR20 Int Dairy J 11:19–25CrossRef

Gopal KP, Prosad J, Gill HS (2003) Effects of the consumption of Bifidobacterium lactis HN019 (DR10TM) and galacto-oligosaccharides on the microflora of the gastrointestinal tract in human subjects. Nutr Res 23:1313–1328CrossRef

van den Heuvel EGHM, Schaafsma G, Muys T, Dokkum W van (1998) Nondigestible oligosaccharides do not interfere with calcium and nonheme-iron absorption in young, healthy men. Am J Clin Nutr 67:445–451

van den Heuvel EGHM, Schoterman MHC, Muijs T (2000) Transgalactooligosaccharides Stimulate Calcium Absorption in Postmenopausal Women J Nutr 130:2938–2942

Hamosh M (2001) Bioactive factors in human milk. Pediatr Clin North Am 48:69–86CrossRef

Holma R, Juvonen P, Asmawi MZ, Vapaatalo H, Korpela R (2002) Galacto-oligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats. Scand J Gastroenterol 37:1042–1047CrossRef

Hopkins MJ, Macfarlane GT (2003) Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl Environ Microbiol 69:1920–1927CrossRef

Hopkins MJ, Cummings JH, Macfarlane GT (1998) Inter-species differences in maximum specific growth rates and cell yields of bifidobacteria cultured on oligosaccharides and other simple carbohydrate sources. J Appl Microbiol 85:381–386CrossRef

Hoyles L, Vulevic J (2008) GI Microbiota and Regulation of the Immune System. In: Huffnagle GB, Noverr MC (ed) Landes Biosciences, Texas, pp. 79–92

Hung MN, Xia Z, Hu NT, Lee BH (2001) Molecular and biochemical analysis of two beta-galactosidases from Bifidobacterium infantis HL96. Appl Environ Microbiol 67:4256–4263CrossRef

Ishizaka S, Kikuchi E, Tsujii T (1993) Effects of acetate on human immune system. Immunopharmacol Immunotoxicol 15:151–162CrossRef

Ito M, Deguchi Y, Matsumoto K, Kimura M, Onodera N, Yajima T (1993) Influence of galactooligosaccharides on the human fecal microflora. J Nutr Sci Vitaminol 39:635–640

Jørgensen F, Hansen OC, Stougaard P (2001) High-efficiency synthesis of oligosaccharides with a truncated beta-galactosidase from Bifidobacterium bifidum. Appl Microbiol Biotechnol 57:647–652CrossRef

Kikuchi H, Andrieux C, Riottot M, Bensaada M, Popot F, Beaumatin P, Szylit O (1996) Effect of two levels of transgalactosylated oligosaccharide intake in rats associated with human faecal microflora on bacterial glycolytic activity, end-products of fermentation and bacterial steroid transformation. J Appl Bacteriol 80:439–446

Kim TB, Song SH, Kang SC, Oh DK (2005) Quantitative comparison of lactose and glucose utilization in Bifidobacterium longum cultures. Biotechnol Prog 19:672–675CrossRef

Kirjavainen PV, Arvola T, Salminen SJ, Isolaurie E (2002) Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51:51–55CrossRef

Knol J, Scholtens B, Kafka C, Steenbakkers J, Gro S, Helm K, Klarczyk M, Schopfer H, Bockler HM,Wells J (2005) Colon Microflora in Infants Fed Formula with Galacto- and Fructo-Oligosaccharides: More Like Breast-Fed Infants. J Pediatr Gastroenterol Nutr 40:36–42CrossRef

Kukkonen K, Savilahti E, Haahtela T, Juntunen Backman K, Korpela R, Poussa T, Turre T, Kuitunen M (2006) Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial J Allergy Clin Immunol 119:192–198CrossRef

Kunz C, Rudloff S, SchadW, Braun D (1999) Lactose-derived oligosaccharides in the milk of elephants: comparison with human milk. Br J Nutr 82(5):391–399CrossRef

van Laere KM, Abee T, Schols HA, Beldman G, Voragen AG (2000) Characterization of a novel beta-galactosidase from Bifidobacterium adolescentis DSM 20083 active towards transgalactooligosaccharides. Appl Environ Microbiol 66:1379–1384CrossRef

Lewis S, Burmeister S, Brazier J (2005) Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol 3:442–448CrossRef

van Loo J, Cummings J, Delzenne N, Englyst H, Franck A, Hopkins M, Kok N (1999) Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095). Br J Nutr 81:121–132

Lunderquist B, Nord C, Winberg J (1985) The composition of the faecal microflora in breast-fed and bottle-fed infants from birth to eight weeks. Acta Paediatr Scand 74:45–51CrossRef

McBain AJ, Macfarlane GT (2001) Modulation of genotoxic enzyme activities by non-digestible oligosaccharide metabolism in in-vitro human gut bacterial ecosystems. J Med Microbiol 50:833–842

Møller PL, Jørgensen F, Hansen OC, Madsen SM, Stougaard P (2001) Intra- and extracellular beta-galactosidases from Bifidobacterium bifidum and B. infantis: molecular cloning, heterologous expression, and comparative characterization. Appl Environ Microbiol 67:2276–2283CrossRef

Moro GE, Arslanoglu S, Stahl B, Jelinek U, Wahn U, Boehm G (2006) A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age Arch Dis Child 91:814–819CrossRef

Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS (2005) Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 135:1304–1307

Newburg DS, Ruiz-Palacios GM, Morrow AL (2005) Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 25:37–58CrossRef

Ohtsuka K, Benno Y, Endo A, Ueda H, Ozawa O, Uchida T, Mitsouka T (1989) Effects of 49 galactosyllactose intake on human fecal microflora. Bifidus 2:143–149

Parche S, Amon J, Jankovic I, Rezzonico E, Beleut M, Barutçu H, Schendel I, Eddy MP, Burkovski A, Arigoni F, Titgemeyer F (2007) Sugar transport systems of Bifidobacterium longum NCC2705. J Mol Microbiol Biotechnol 12:9–19CrossRef

Parche S, Beleut M, Rezzonico E, Jacobs D, Arigoni F, Titgemeyer F, Jankovic I (2006) Lactose-over-glucose preference in Bifidobacterium longum NCC2705: glcP, encoding a glucose transporter, is subject to lactose repression. J Bacteriol 188:1260–1265CrossRef

Playne MJ (2002) The health benefits of probiotics. In Encyclopaedia of dairy sciences, Academic Press London pp. 1151–1158

Rowland IR, Tanaka R (1993) The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J Appl Bacteriol 74:667–674

Rudloff S, Stefan C, Pohlentz G (2002) Detection of ligands for selectins in the oligosaccharide fraction of human milk. Eur J Nutr 41:85–92CrossRef

Rycroft CE, Jones MR, Gibson GR, Rastall RA (2001) A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91:878–887CrossRef

Sairanen U, Piirainen L, Nevala R, Korpela R (2007) Yoghurt containing galacto-oligosaccharides, prunes and linseed reduces the severity of mild constipation in elderly subjects. Eur J Clin Nutr 61:1423–1428CrossRef

Satokari RM, Vaughn EE, Akkermans ADL, Saarela M, de VOS WM (2001) Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67:504–13CrossRef

Schell MA, Karmirantzou M, Snel B, Vilanova D, Berger B, Pessi G, Zwahlen MC, Desiere F, Bork P, Delley M, Pridmore RD, Arigoni F (2002) The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci USA 99:14422–14427CrossRef

Searle LEJ, Best A, Nunez A, Salguero FJ, Johnson L, Weyer U, Dugdale AH, Cooley WA, Carter B, Jones G, Tzortzis G, Woodward MJ, La Ragione RM (2009) A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice. J Med Microbiol 58:37–48CrossRef

Sela DA, Chapman J, Adeuya A, Kim JH, Chen F,Whitehead TR, Lapidus A, Rokhsar DS, Lebrilla CB, German JB, Price NP, Richardson PM, Mills DA (2008) The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci USA 105(48):18964–18969CrossRef

Sharp R, Fishbain S, Macfarlane GT (2001) Effect of short-chain carbohydrates on human intestinal bifidobacteria and Escherichia coli in vitro. J Med Microbiol 50:152–160

Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW (2006) Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun 74:6920–6928CrossRef

Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR (2009) Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29 (5):508–518CrossRef

Splechtna B, Petzelbauer I, Baminger U, Haltrich D, Kulbe DK, Nidetzky B (2001) Production of a lactose-free galacto-oligosaccharide mixture by using selective enzymatic oxidation of lactose into lactobionic acid Enz Micro Technol 29:434–440CrossRef

Tanaka R, Takayama H, Morotomi M, Kuroshima T, Ueyama S, Matsumoto K, Kuroda A, Mutai M (1983) Effects of administration of TOS and Bifidbacterium breve 4006 on the human flora. Bifidobacteria Microflora 2:17–24

Teuri U, Korpela R, Saxelin M, Montonen L, Salminen S (1998) Increased fecal frequency and gastrointestinal symptoms following ingestion of galacto-oligosaccharide-containing yogurt. J Nutr Sci Vitaminol 44:465–471

Tochikura R, Sakai K, Fujiyoshi T, Tachiki T, Kumagai H (1986) p-Nitrophenyl glycoside-hydrolyzing activities in Bifidobacteria and characterization of β-D-galactosidase of Bifidobacterium longum 401 Agric Biol Chem 50:2279–2286

Tzortzis G, Goulas AK, Gee JM, Gibson GR (2005) A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo. J Nutr 135:1726–1731

Veereman-Wauters G (2005) Application of prebiotics in infant foods. Br J Nutr 93: S57–S60CrossRef

Vulevic J, Rastall RA, Gibson GR (2004) Developing a quantitative approach for determining the in vitro prebiotic potential of dietary oligosaccharides. FEMS Microbiol Lett 236:153–159CrossRef

Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR (2008) Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 88 (5): 1438–1446

Wijnands MVW, Schoterman HC, Bruijntjes JP, Hollanders VMH, Woutersen RA (2001) Effect of dietary galacto-oligosaccharides on azoxymethane-induced aberrant crypt foci and colorectal cancer in Fischer 344 rats Carcinogenesis 22:127–132CrossRef

Titel: Galacto-Oligosaccharide Prebiotics
verfasst von: George Tzortzis
Jelena Vulevic
Verlag: Springer New York
Buch: Prebiotics and Probiotics Science and Technology
Print ISBN: 978-0-387-79057-2

Electronic ISBN: 978-0-387-79058-9

Copyright-Jahr: 2009
DOI: https://doi.org/10.1007/978-0-387-79058-9_7

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht